| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |